Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-12

Clinical Trial Update: Teriparatide as a Chondroregenerative Therapy in OA [Phase 2]

View source ↗

Summary

Phase 2 trial investigating teriparatide as a chondroregenerative therapy in knee osteoarthritis and cartilage degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: Christopher Ritchlin | Conditions: Knee Osteoarthritis, Cartilage Degeneration | Phase 2 | Status: COMPLETED